array bridge代理

详细介绍

产品咨询

世界*实验材料供应商ARRAY BRIDGE上海金畔生物为其中国代理，ARRAY BRIDGE 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， ARRAY BRIDGE 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

ARRAY BRIDGE 中国代理，ARRAY BRIDGE 上海代理，ARRAY BRIDGE北京代理， ARRAY BRIDGE 广东代理，ARRAY BRIDGE 江苏代理 ARRAY BRIDGE 湖北代理, ARRAY BRIDGE 天津, ARRAY BRIDGE 黑龙江代理, ARRAY BRIDGE内蒙古代理, ARRAY BRIDGE 吉林代理, ARRAY BRIDGE 福建代理, ARRAY BRIDGE 江苏代理, ARRAY BRIDGE 浙江代理, ARRAY BRIDGE 四川代理,

www.arraybridge.com

Array Bridge Inc. was founded by scientists with extensive experience in drug discovery and biologics development.  Array Bridge provides products and services that address two important areas in the development of biologics: biosimilar drug comparability analysis and impurity analysis.   

During biosimilar development, biologics comparability is critical to the successful development of the process and product. From cell line selection to process development, from formulation development to change control, comparability is closely related to the molecule¿s safety and efficacy. Array Bridge has developed “antibody arrays” to measure biosimilar drug comparability at the molecular level, providing a sensitive, systematic and robust measurement of biosimilar conformational comparability. This antibody array-based technology can be used at all stages of biosimilar development, from cell line selection and process development to clinical testing and product release. 

For impurity analysis, Array Bridge provides ELISA kits and reagents for Host Cell Protein quantitation and Western Blot analysis. All the products are manufactured under cGMP to ensure quality and consistency. In the near future, Array Bridge will also provide Q-PCR-based residual DNA quantitation kits for CHO and E. coli-derived biologics and an ELISA kit for residual Protein A quantitation.  

In addition to these products, Array Bridge also provide services to the biotech and life science industries. If you need to analyze your samples for impurities (Host Cell Proteins, residual DNA or Protein A) or for biosimilar conformational comparability, Array Bridge has scientists with experience working under cGMP and ICH guidelines to deliver regulatory-ready results and documentation. Furthermore, we can help you with ELISA method qualification or validation. The company also provides consultation for the development of an effective impurity analysis strategy, enabling your program(s) to meet requirements from regulatory agencies such as FDA and EMA.   In addition, we provide enzyme assays for over 850 enzymes, the most extensive enzyme assay collection in one place.

专注领域

Biosimilar 3-D conformational comparability, Host Cell Protein Analysis, Process-related impurity analysis, Antibody-drug conjugate development, Residual DNA analysis, Bioassay method qualification and validation

上海金畔生物科技有限公司